News

The UK government has put forth its intention to invest £260 million in cutting-edge medical research and development, as well as the manufacturing of innovative pharmaceuticals, gadgets, and diagnostics. Through digital clinical trial services and Trusted Research Environments, the Department of...

The head of the NHS revealed today that a breakthrough targeted medication treating lung cancer would be made accessible to anybody who qualifies, owing to a new drug deal. Sotorasib is a drug that targets a genetic abnormality known...

Croda International Plc, which uses smart science to improve lives, announces that it has entered a strategic collaboration with Statens Serum Institut (“SSI”), the leading Danish Governmental life-science research institute. Croda’s vaccine adjuvant specialists, based in Denmark, will exclusively manufacture,...

AbbVie announced it has completed the acquisition of Syndesi Therapeutics SA, which will help to expand AbbVie's neuroscience portfolio. This acquisition gives AbbVie access to Syndesi's portfolio of novel modulators of the synaptic vesicle protein 2A (SV2A), including its...

IDT Biologika, a leading Contract Development and Manufacturing Organization (CDMO) specialized in vaccines, gene and immune therapy and oncolytic viruses, and Exothera S.A. collaborate to develop a large-scale manufacturing process for viral vector-based vaccines. The feasibility study is focussing...

The U.S. Food and Medication Administration authorised CTI BioPharma Corp's drug for treating adult patients with a kind of bone marrow cancer who also have a low blood platelet count. Vonjo (pacritinib) belongs to a class of anti-inflammatory drugs...

INCOG BioPharma Services announces it has completed the construction of its Quality Control testing laboratories, as well as the technology transfer and scale-up suite, at its headquarters in Fishers, Indiana. Shortly after INCOG employees moved into their new offices,...